10.50 - 11.12
3.81 - 12.83
1.80M / 1.60M (Avg.)
158.14 | 0.07
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
31.84%
EBIT growth 75-90% of ITRG's 36.46%. Bill Ackman would push for cost reforms or better product mix to narrow the gap.
31.84%
Positive operating income growth while ITRG is negative. John Neff might view this as a competitive edge in operations.
32.55%
Positive net income growth while ITRG is negative. John Neff might see a big relative performance advantage.
32.46%
Positive EPS growth while ITRG is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
32.46%
Positive diluted EPS growth while ITRG is negative. John Neff might view this as a strong relative advantage in controlling dilution.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
71.10%
OCF growth at 75-90% of ITRG's 91.85%. Bill Ackman would demand better working capital management or cost discipline.
71.40%
FCF growth 75-90% of ITRG's 92.41%. Bill Ackman might push for improved capital allocation or operational changes to match the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-81.60%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-81.60%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-81.60%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
75.43%
Net income/share CAGR at 75-90% of ITRG's 86.56%. Bill Ackman would press for strategic moves to boost long-term earnings.
75.43%
5Y net income/share CAGR at 75-90% of ITRG's 86.56%. Bill Ackman would advocate improvements to match competitor’s profit expansion.
75.43%
3Y net income/share CAGR 75-90% of ITRG's 86.56%. Bill Ackman might push for an operational plan to match or beat the competitor’s short-term growth.
-78.19%
Negative equity/share CAGR over 10 years while ITRG stands at 6.82%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-78.19%
Negative 5Y equity/share growth while ITRG is at 6.82%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-78.19%
Negative 3Y equity/share growth while ITRG is at 6.82%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-61.71%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-100.00%
Inventory is declining while ITRG stands at 0.00%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-3.10%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-8.83%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-32.93%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.